BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16035612)

  • 1. Roles for neuregulins in human cancer.
    Stove C; Bracke M
    Clin Exp Metastasis; 2004; 21(8):665-84. PubMed ID: 16035612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EGF receptor family--multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4.
    Earp HS; Calvo BF; Sartor CI
    Trans Am Clin Climatol Assoc; 2003; 114():315-33; discussion 333-4. PubMed ID: 12813928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuregulin Signaling in the Tumor Microenvironment.
    Jia R; Zhao H; Wang S
    Adv Exp Med Biol; 2021; 1270():1-29. PubMed ID: 33123990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ErbB/HER family of receptor tyrosine kinases: A potential target for chemoprevention of epithelial neoplasms.
    Kirschbaum MH; Yarden Y
    J Cell Biochem Suppl; 2000; 34():52-60. PubMed ID: 10762015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neuregulin4 and HER4 in gastrointestinal malignant lymphoma.
    Ebi M; Kataoka H; Shimura T; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Tsukamoto H; Ozeki K; Tanida S; Kamiya T; Inagaki H; Joh T
    Mol Med Rep; 2011; 4(6):1151-5. PubMed ID: 21805036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin and ErbB receptor signaling pathways in the nervous system.
    Buonanno A; Fischbach GD
    Curr Opin Neurobiol; 2001 Jun; 11(3):287-96. PubMed ID: 11399426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
    Yarden Y
    Eur J Cancer; 2001 Sep; 37 Suppl 4():S3-8. PubMed ID: 11597398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
    Earp HS; Dawson TL; Li X; Yu H
    Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuregulins and cancer.
    Montero JC; Rodríguez-Barrueco R; Ocaña A; Díaz-Rodríguez E; Esparís-Ogando A; Pandiella A
    Clin Cancer Res; 2008 Jun; 14(11):3237-41. PubMed ID: 18519747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin promotes autophagic cell death of prostate cancer cells.
    Tal-Or P; Di-Segni A; Lupowitz Z; Pinkas-Kramarski R
    Prostate; 2003 May; 55(2):147-57. PubMed ID: 12661040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
    Riese DJ; Bermingham Y; van Raaij TM; Buckley S; Plowman GD; Stern DF
    Oncogene; 1996 Jan; 12(2):345-53. PubMed ID: 8570211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system.
    Britsch S; Li L; Kirchhoff S; Theuring F; Brinkmann V; Birchmeier C; Riethmacher D
    Genes Dev; 1998 Jun; 12(12):1825-36. PubMed ID: 9637684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the EGF/HER Ligand-Receptor System in Cancer.
    Esparís-Ogando A; Montero JC; Arribas J; Ocaña A; Pandiella A
    Curr Pharm Des; 2016; 22(39):5887-5898. PubMed ID: 27426127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes.
    Prevot V; Rio C; Cho GJ; Lomniczi A; Heger S; Neville CM; Rosenthal NA; Ojeda SR; Corfas G
    J Neurosci; 2003 Jan; 23(1):230-9. PubMed ID: 12514220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.